Role of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with acute pulmonary embolism.

Schroeder, Verena; Kucher, N; Kohler, H P (2003). Role of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with acute pulmonary embolism. Journal of thrombosis and haemostasis, 1(3), pp. 492-493. Blackwell 10.1046/j.1538-7836.2003.00112.x

[img] Text
Schroeder_et_al-2003-Journal_of_Thrombosis_and_Haemostasis.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (55kB) | Request a copy

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > Forschungsbereich Pavillon 52 > Forschungsgruppe Experimentelle Hämostase

UniBE Contributor:

Schröder, Verena

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1538-7933

Publisher:

Blackwell

Language:

English

Submitter:

Marla Rittiner

Date Deposited:

14 Jan 2020 11:16

Last Modified:

14 Jan 2020 11:16

Publisher DOI:

10.1046/j.1538-7836.2003.00112.x

PubMed ID:

12871455

BORIS DOI:

10.7892/boris.138297

URI:

https://boris.unibe.ch/id/eprint/138297

Actions (login required)

Edit item Edit item
Provide Feedback